Difference between revisions of "Part:BBa K5531010"

 
Line 1: Line 1:
  
−
__NOTOC__
 
 
<partinfo>BBa_K5531010 short</partinfo>
 
<partinfo>BBa_K5531010 short</partinfo>
  
−
pET-Dual-HisRh3C-P15VP4-P4H
 
−
 
−
 
−
<!-- Add more about the biology of this part here
 
−
===Usage and Biology===
 
  
 
<!-- -->
 
<!-- -->
Line 14: Line 8:
  
  
−
<!-- Uncomment this to enable Functional Parameter display
+
<!DOCTYPE html>
−
===Functional Parameters===
+
<html lang="en">
−
<partinfo>BBa_K5531010 parameters</partinfo>
+
<head>
−
<!-- -->
+
    <meta charset="UTF-8">
 +
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
 +
    <title>BBa_K5531010 (pET-Dual-HisRh3C-P15VP4-P4H)</title>
 +
    <style>
 +
        img {
 +
            max-width: 80%; /* Adjust this percentage to change size relative to text */
 +
            height: auto; /* Maintain aspect ratio */
 +
        }
 +
        .caption {
 +
            text-align: center;
 +
            font-size: 0.9em;
 +
            margin-top: 5px;
 +
            margin-bottom: 20px; /* Space below the caption */
 +
        }
 +
    </style>
 +
</head>
 +
<body>
 +
    <h2>BBa_K5531010 (pET-Dual-HisRh3C-P15VP4-P4H)</h2>
 +
 
 +
    <h3>Construction Design</h3>
 +
    <p>
 +
        This targeted gene, Rh3C-P15VP4 (BBa_K5531000), synthesized by a biotech company, contains humanized type III collagen fused with the VP4 protein from the rotavirus with serotype P15. Meanwhile, P4H (BBa_K5531012) is also co-expressed in this plasmid due to the lack of proline hydroxylation-modifying enzymes (prolyl 4-hydroxylases (P4H)) in <em>procaryotes</em>, which is essential for collagen stability. The pET-Dual-N-His-TEV (BBa_K5531006) serves as the vector. The homologous recombination method was employed to construct pET-Dual-HisRh3C-P15VP4-P4H (BBa_K5531010).
 +
    </p>
 +
 
 +
    <!-- Figure 1 -->
 +
    <div style="text-align:center;">
 +
        <img src="https://static.igem.wiki/teams/5531/bba-k55310010/1.png" alt="Figure 1: Plasmid map of pET-Dual-HisRh3C-P15VP4-P4H">
 +
        <div class="caption">Fig. 1. Plasmid map of pET-Dual-HisRh3C-P15VP4-P4H</div>
 +
    </div>
 +
 
 +
    <h3>Experimental Approach</h3>
 +
    <p>
 +
        We isolated pET-Dual-N-His-TEV vectors from bacterial solutions primarily by centrifugation. The vectors were then obtained from the remains in the absorption column. Subsequently, we linearized the vectors using restriction enzymes and conducted electrophoresis to analyze the products. The electrophoresis result displayed correctness toward the expected outcome (HisRh3C-P15VP4 is 2000 bp, and P4H is 755 bp). We selected colonies and sent them directly for sequencing. Figure 2 shows the success of pET-Dual-HisRh3C-P15VP4-P4H construction.
 +
    </p>
 +
 
 +
    <!-- Figure 2 -->
 +
    <div style="text-align:center;">
 +
        <img src="https://static.igem.wiki/teams/5531/bba-k55310010/2.png" alt="Figure 2: The results of pET-Dual-HisRh3C-P15VP4-P4H">
 +
        <div class="caption">Fig. 2. The results of pET-Dual-HisRh3C-P15VP4-P4H</div>
 +
    </div>
 +
 
 +
    <h3>Characterization/Measurement</h3>
 +
    <p>
 +
        Later, the plasmid mounted with the gene of Rh3C-P15VP4 was transferred to <em>E. coli</em> DH5α to replicate. The extracted plasmid was transferred into <em>E. coli</em> BL21, which can help express His-Rh3C-P15VP4. After the colony PCR of <em>E. coli</em> BL21 was finished and verified, the bacteria were cultured and treated with 0.2 mM IPTG, which can promote protein expression. After promoting the protein expression overnight, the protein was purified via His-tag Purification Resin and went through SDS-PAGE electrophoresis and Native-PAGE electrophoresis. The target protein Rh3C-P15VP4 has a size of 85 kDa.
 +
    </p>
 +
 
 +
    <!-- Figure 3 -->
 +
    <div style="text-align:center;">
 +
        <img src="https://static.igem.wiki/teams/5531/bba-k55310010/3.png" alt="Figure 3: The expression of His-Rh3C-P15VP4 using E. coli BL21.">
 +
        <div class="caption">Fig. 3. The expression of His-Rh3C-P15VP4 using E. coli BL21.</div>
 +
    </div>
 +
 
 +
    <p>
 +
        Collagen of the C-D-E-VP4 complex (in a 1:1:1 ratio) was diluted to a concentration of 0.5 mg/mL and incubated at 37°C for 1 hour before undergoing native-PAGE and SEC analysis. As illustrated in Figure 4, the samples were divided into two distinct clusters: high-molecular-weight and low-molecular-weight states. Each cluster contained multiple bands, indicative of varying degrees of proline hydroxylation. Based on the construct design, we hypothesized that the high-molecular-weight clusters represented the trimer assemblies, while the low-molecular-weight clusters corresponded to the monomers. This hypothesis was confirmed by the SEC analysis, as depicted in Figure 4. The peaks for the C-D-E-VP4 complex also ranged from 0.5 to 0.8 CV, with the prominent peaks at 0.56 CV and 0.66 CV, indicating the presence of trimer and monomer macromolecules.
 +
    </p>
 +
 
 +
    <!-- Figure 4 -->
 +
    <div style="text-align:center;">
 +
        <img src="https://static.igem.wiki/teams/5531/bba-k55310010/4.jpg" alt="Figure 4: Native-PAGE analysis of oligomeric states of collagen C-D-E complex.">
 +
        <div class="caption">Fig. 4. Native-PAGE analysis (left) of oligomeric states of collagen C-D-E complex; Size exclusion chromatographic (SEC) analysis (right) of oligomeric states of collagen C-D-E complex.</div>
 +
    </div>
 +
 
 +
    <h3>References</h3>
 +
    <p>
 +
        [1] Gauba V, Hartgerink JD. Self-assembled heterotrimeric collagen triple helices directed through electrostatic interactions. <em>J Am Chem Soc</em>. 2007 Mar 7;129(9):2683-90.<br>
 +
        [2] Liu Zezhong; Zhou Jie; Zhu Yun; Lu Lu; Jiang Shibo; School of Basic Medical Sciences, Fudan University; Department of Pharmacology, School of Pharmacy, Fudan University; Institute of Biophysics, Chinese Academy of Sciences.
 +
    </p>
 +
 
 +
</body>
 +
</html>

Revision as of 10:45, 29 September 2024

pET-Dual-HisRh3C-P15VP4-P4H


Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    INCOMPATIBLE WITH RFC[12]
    Illegal NheI site found at 6594
    Illegal NotI site found at 150
  • 21
    INCOMPATIBLE WITH RFC[21]
    Illegal BglII site found at 305
    Illegal BamHI site found at 119
    Illegal XhoI site found at 354
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    INCOMPATIBLE WITH RFC[25]
    Illegal NgoMIV site found at 324
    Illegal NgoMIV site found at 671
    Illegal NgoMIV site found at 5341
  • 1000
    INCOMPATIBLE WITH RFC[1000]
    Illegal BsaI.rc site found at 1256


<!DOCTYPE html> BBa_K5531010 (pET-Dual-HisRh3C-P15VP4-P4H)

BBa_K5531010 (pET-Dual-HisRh3C-P15VP4-P4H)

Construction Design

This targeted gene, Rh3C-P15VP4 (BBa_K5531000), synthesized by a biotech company, contains humanized type III collagen fused with the VP4 protein from the rotavirus with serotype P15. Meanwhile, P4H (BBa_K5531012) is also co-expressed in this plasmid due to the lack of proline hydroxylation-modifying enzymes (prolyl 4-hydroxylases (P4H)) in procaryotes, which is essential for collagen stability. The pET-Dual-N-His-TEV (BBa_K5531006) serves as the vector. The homologous recombination method was employed to construct pET-Dual-HisRh3C-P15VP4-P4H (BBa_K5531010).

Figure 1: Plasmid map of pET-Dual-HisRh3C-P15VP4-P4H
Fig. 1. Plasmid map of pET-Dual-HisRh3C-P15VP4-P4H

Experimental Approach

We isolated pET-Dual-N-His-TEV vectors from bacterial solutions primarily by centrifugation. The vectors were then obtained from the remains in the absorption column. Subsequently, we linearized the vectors using restriction enzymes and conducted electrophoresis to analyze the products. The electrophoresis result displayed correctness toward the expected outcome (HisRh3C-P15VP4 is 2000 bp, and P4H is 755 bp). We selected colonies and sent them directly for sequencing. Figure 2 shows the success of pET-Dual-HisRh3C-P15VP4-P4H construction.

Figure 2: The results of pET-Dual-HisRh3C-P15VP4-P4H
Fig. 2. The results of pET-Dual-HisRh3C-P15VP4-P4H

Characterization/Measurement

Later, the plasmid mounted with the gene of Rh3C-P15VP4 was transferred to E. coli DH5α to replicate. The extracted plasmid was transferred into E. coli BL21, which can help express His-Rh3C-P15VP4. After the colony PCR of E. coli BL21 was finished and verified, the bacteria were cultured and treated with 0.2 mM IPTG, which can promote protein expression. After promoting the protein expression overnight, the protein was purified via His-tag Purification Resin and went through SDS-PAGE electrophoresis and Native-PAGE electrophoresis. The target protein Rh3C-P15VP4 has a size of 85 kDa.

Figure 3: The expression of His-Rh3C-P15VP4 using E. coli BL21.
Fig. 3. The expression of His-Rh3C-P15VP4 using E. coli BL21.

Collagen of the C-D-E-VP4 complex (in a 1:1:1 ratio) was diluted to a concentration of 0.5 mg/mL and incubated at 37°C for 1 hour before undergoing native-PAGE and SEC analysis. As illustrated in Figure 4, the samples were divided into two distinct clusters: high-molecular-weight and low-molecular-weight states. Each cluster contained multiple bands, indicative of varying degrees of proline hydroxylation. Based on the construct design, we hypothesized that the high-molecular-weight clusters represented the trimer assemblies, while the low-molecular-weight clusters corresponded to the monomers. This hypothesis was confirmed by the SEC analysis, as depicted in Figure 4. The peaks for the C-D-E-VP4 complex also ranged from 0.5 to 0.8 CV, with the prominent peaks at 0.56 CV and 0.66 CV, indicating the presence of trimer and monomer macromolecules.

Figure 4: Native-PAGE analysis of oligomeric states of collagen C-D-E complex.
Fig. 4. Native-PAGE analysis (left) of oligomeric states of collagen C-D-E complex; Size exclusion chromatographic (SEC) analysis (right) of oligomeric states of collagen C-D-E complex.

References

[1] Gauba V, Hartgerink JD. Self-assembled heterotrimeric collagen triple helices directed through electrostatic interactions. J Am Chem Soc. 2007 Mar 7;129(9):2683-90.
[2] Liu Zezhong; Zhou Jie; Zhu Yun; Lu Lu; Jiang Shibo; School of Basic Medical Sciences, Fudan University; Department of Pharmacology, School of Pharmacy, Fudan University; Institute of Biophysics, Chinese Academy of Sciences.